Biohaven Ltd. Common Shares (BHVN)
BHVN trades on NYSE in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$11.42
-3.30% on the day
Market cap
$1.7B
Small cap
Revenue
Not reported in SEC XBRL data
Net income
Not reported in SEC XBRL data
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | BHVN on NYSE |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | 2022 |
| SEC CIK | 0001935979 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | D8 |
Financials
Not reported in SEC XBRL data.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B5 | 2026-05-04 |
| Latest annual report | 10-K | 2026-03-02 |
| Latest quarterly / interim | 10-Q | 2026-08-10 |
| Latest current report | 8-K | 2026-09-10 |
| Latest proxy | DEFA14A | 2026-03-13 |
Source: SEC EDGAR submissions feed, 278 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -8.5% |
| 1 month | -11.9% |
| 3 months | -23.3% |
| Year to date | -3.7% |
| 1 year | -29.0% |
| From 52-week high | -40.0% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| BRVE | Braveheart Bio Inc. | $19.33 | -5.06% | $1.7B |
| SRPT | Sarepta Therapeutics Inc. Common Stock (DE) | $16.51 | -5.33% | $1.7B |
| XNCR | Xencor Inc. | $23.52 | -6.07% | $1.7B |
| SEPN | Septerna Inc. | $36.41 | -3.05% | $1.7B |
| TRVI | Trevi Therapeutics Inc. | $12.29 | -4.95% | $1.8B |
| MRVI | Maravai LifeSciences Holdings Inc. | $6.53 | -7.51% | $1.7B |
| ZYME | Zymeworks Inc. | $25.07 | -1.03% | $1.8B |
| NUVB | Nuvation Bio Inc. | $4.72 | -3.67% | $1.7B |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier